BGI Group
Company Snapshot
Founded: 1999
Entity Type: Private
Region: China
Headquarter: China
Corporate Address: Building 11, Beishan Industrial Zone, Yantian District, Shenzhen 518083 China Tel. +86-755-3630-7888 www.en.genomics.cn
Company Overview
BGI Genomics, a subsidiary of BGI Group, is a leading integrated solutions provider of precision medicine. The company offers clinical molecular diagnostics and high-throughput sequencing services in more than 100 countries, having sequenced more than 150,000 human genomes.
The NIFTY test, the pioneering NIPT since 2010, validated in a study of 147,000 pregnancies, conducted more than 10 million tests globally by December 2021. Although not FDA-approved, BGI, with more than 3 million processed samples, currently introduces a local laboratory solution utilizing its BGISEQ-500 sequencing platform for advanced NIPT testing, featuring combinatorial probe-anchor synthesis (cPAS) and improved DNA nanoballs (DNB) technology.
BGI Group In News
Company's Business Segments
- Scientific : This segment includes Human Genetics Research, Animal and Plant Research.
- Technology : This segment includes Disease Research, Plant and Animal Research, Microbiological Research.
- Diagnostics : This segment includes Clinical Testing, In Vitro Diagnostic.
- Instrument Platform : This segment includes Sequencer Products, Lab Automation Products, Novel Products.
Applications/End User Industries
- Library Prep Kits
- Sequencing Reagents
- Single-Cell Platform
- Reproductive Health
- Genetic Counseling
- Tumor Prevention
- Testing Services
- Reagent Products
- Disease Research
- Genetics Research
- Plant Research
- Animal Research
- Microbiological Research
- Medical Institutions
- Research Institutions
- Organizations
BCC Research Beacon 